Mangompit, Ailyn .

HRN: 07-87-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2024
CO-AMOXICLAV 625MG (TAB)
05/01/2024
05/07/2024
ORAL
1 Tab
2x A Day
NSVD With Perineorrhaphy
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: